Who owns Adverum Biotechnologies, Inc.?
- Ticker: ADVM
- CUSIP Number: 00773u207
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 2.3M | $16M | 15% | Sep 2024 |
|
| Franklin Resources | 1.8M | $14M | 0% | Sep 2024 |
|
| BlackRock | 1.5M | $11M | 100% | Sep 2024 |
|
| VR Adviser | 1.5M | $10M | 0% | Sep 2024 |
|
| BlackRock | 1.4M | $9.7M | 345% | Jun 2024 |
|
| Frazier Life Sciences Management | 1.1M | $7.5M | 0% | Sep 2024 |
|
| Vanguard Group | 1.0M | $6.9M | 11% | Jun 2024 |
|
| 5AM Venture Management | 542k | $3.8M | 0% | Sep 2024 |
|
| Geode Capital Management | 439k | $3.1M | -4% | Sep 2024 |
|
| Logos Global Management | 417k | $2.9M | -72% | Jun 2024 |
|
| Goldman Sachs Group | 397k | $2.7M | 100% | Jun 2024 |
|
| Pale Fire Capital SE | 308k | $2.2M | 100% | Sep 2024 |
|
| State Street Corporation | 279k | $1.9M | 330% | Jun 2024 |
|
| Dimensional Fund Advisors | 207k | $1.5M | -7% | Sep 2024 |
|
| Northern Trust | 155k | $1.1M | 322% | Sep 2024 |
|
| Soleus Capital Management | 147k | $1.0M | 100% | Jun 2024 |
|
| Morgan Stanley | 129k | $887k | -77% | Jun 2024 |
|
| Squarepoint Ops | 109k | $748k | 301% | Jun 2024 |
|
| Two Sigma Investments | 77k | $531k | 553% | Jun 2024 |
|
| Nuveen Asset Management | 69k | $470k | 100% | Jun 2024 |
|
| AQR Capital Management | 60k | $421k | 100% | Sep 2024 |
|
| Charles Schwab Investment Management | 60k | $419k | 0% | Sep 2024 |
|
| Citadel Advisors | 53k | $370k | -66% | Sep 2024 |
|
| Bank of New York Mellon | 48k | $339k | -25% | Sep 2024 |
|
| Marshall Wace | 43k | $301k | -79% | Sep 2024 |
|
| Grant/GrossMendelsohn | 39k | $271k | 100% | Sep 2024 |
|
| Bank of America Corporation | 38k | $263k | -79% | Sep 2024 |
|
| Renaissance Technologies | 37k | $260k | -73% | Sep 2024 |
|
| Trexquant Investment | 36k | $252k | 100% | Sep 2024 |
|
| Barclays | 36k | $252k | 126% | Sep 2024 |
|
| Rhumbline Advisers | 32k | $227k | 5% | Sep 2024 |
|
| Quinn Opportunity Partners | 27k | $184k | 0% | Jun 2024 |
|
| ExodusPoint Capital Management | 25k | $173k | 100% | Sep 2024 |
|
| Group One Trading | 25k | $172k | 128668% | Sep 2024 |
|
| Assenagon Asset Management | 23k | $164k | -96% | Sep 2024 |
|
| Two Sigma Advisers | 23k | $157k | 42% | Jun 2024 |
|
| Qube Research & Technologies | 16k | $112k | -61% | Jun 2024 |
|
| Cantor Fitzgerald, L. P. | 15k | $108k | 0% | Sep 2024 |
|
| Sherbrooke Park Advisers | 15k | $107k | 100% | Sep 2024 |
|
| Citigroup | 15k | $106k | 224% | Sep 2024 |
|
| Connor, Clark & Lunn Investment Management | 13k | $93k | 100% | Sep 2024 |
|
| Zacks Investment Management | 13k | $89k | 100% | Sep 2024 |
|
| MetLife Investment Advisors | 13k | $88k | 129% | Sep 2024 |
|
| American Century Companies | 12k | $84k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 12k | $81k | 100% | Sep 2024 |
|
| SG Americas Securities | 11k | $74k | 100% | Sep 2024 |
|
| Captrust Financial Advisors | 10k | $71k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 9.6k | $67k | 5% | Sep 2024 |
|
| Jpmorgan Chase & Co | 9.4k | $66k | 5% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.1k | $29k | 177% | Sep 2024 |
|
| Northwest & Ethical Investments | 3.4k | $23k | 100% | Jun 2024 |
|
| New York State Common Retirement Fund | 3.0k | $21k | -79% | Sep 2024 |
|
| Royal Bank of Canada | 2.1k | $13k | -4% | Sep 2024 |
|
| Summit Investment Advisors | 2.0k | $14k | 0% | Sep 2024 |
|
| nVerses Capital | 1.6k | $11k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 1.5k | $11k | 0% | Sep 2024 |
|
| Tower Research Capital | 1.5k | $10k | 46% | Jun 2024 |
|
| Amalgamated Bank | 720.00 | $5.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 574.00 | $4.0k | -72% | Sep 2024 |
|
| GAMMA Investing | 298.00 | $2.1k | 100% | Sep 2024 |
|
| CWM | 245.00 | $2.0k | 100% | Sep 2024 |
|
| Capital Performance Advisors | 116.00 | $813.995200 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 86.00 | $604.003800 | 100% | Sep 2024 |
|
| Sterling Capital Management | 66.00 | $463.003200 | 100% | Sep 2024 |
|
| Parallel Advisors | 50.00 | $351.000000 | 0% | Sep 2024 |
|
| GHP Investment Advisors | 20.00 | $141.000000 | 0% | Sep 2024 |
|
| Lazard Asset Management | 17.00 | $0 | -63% | Sep 2024 |
|
| Hanson McClain Advisors | 2.00 | $15.000000 | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.00 | $7.000000 | -50% | Sep 2024 |
|
| Frazier Financial Advisors | 1.00 | $8.000000 | 0% | Sep 2024 |
|
Who sold out of Adverum Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Picton Mahoney Asset Management | Jun 2024 | 124k | $850k |
| Millennium Management | Jun 2024 | 69k | $476k |
| Jane Street | Jun 2024 | 29k | $200k |
| Wolverine Trading | Jun 2024 | 25k | $172k |
| Jump Financial | Jun 2024 | 24k | $166k |
| Shay Capital | Mar 2024 | 23k | $331k |
| Belvedere Trading | Jun 2024 | 17k | $12k |
| Balyasny Asset Management | Mar 2024 | 14k | $201k |
| Graham Capital Management | Jun 2024 | 12k | $81k |
| Bayesian Capital Management | Jun 2024 | 11k | $74k |
| Macquarie Group | Mar 2024 | 2.6k | $36.979800 |
| Simplex Trading | Jun 2024 | 322.00 | $2.0k |